FLEX Pharma Inc (fka FLKS)

[lordgod]

New stock symbol is SLRX and it’s opening up at 19.90 a share

[goodplenty100]

Brief summary

FLKS what we know.

25 for 1 RS, new ticker SLRX, warrants and strike price to be posted.

A rights dividend, (see the link) https://www.zacks.com/research/get_news.php?id=vckrklap36

I'll leave my opinion out of this, there is way to much BS going around on other sites in an effort to sway people to work their warrants. Let this link be your guide to make your own informed decisions. It's very simple just be knowledgeable prior to your decision. It's what works for you!

https://www.investopedia.com/ask/answers/how-to-exercise-stock-warrants/

I've heard some accounts have cleared already (don't know if that is true) I have 3 accounts w/FLKS...none show any news.

Oh, and Clay trader is posting, he may be wrong again as he was w/CDMO


Good luck.

[lordgod]

Does name change today .

[jaj-dan]

It was announce 6 days ago that the merger will be completed in one to two weeks. When do you think we see a 8-K filing?

[ClayTrader]

* * $FLKS Video Chart 07-15-2019 * *

Link to Video - click here to watch the technical chart video

[jaj-dan]

And it was over $4 just a little more than a year ago. I’m hoping $1.40-$1.50 is conservative for Monday.

[lordgod]

This stock was at 12 to 20 dollars a share years ago

[samman69]

I don’t see why not, should open over 1.00 I think it will be a roller coaster most of the day buys selling for good profits and why not can’t blame someone for taking over doubling there money, and of course dealing with the shorts BEARS??but IMO Bulls will prevail to around 1.40 to 1.50 we will see. IMO only....!

[lordgod]

Could this be huge Monday

[Heywood4164]

Yes sir closes next week or two

[Heywood4164]

Merger approval!!! Boom

[lordgod]

I think merger happened

[lordgod]

This is very interesting

[sanderburwil]

I would say after hours prob...

[lordgod]

When is news expected ?

[sanderburwil]

Salarius Pharma is a well managed and very promising co. I sure am

[dhoff19]

Will this be a good hold after merger?

[sanderburwil]

$FLKS - Flex Pharma and Salarius Pharma Merger- should see News late afternoon - After Hours and 60-100%+ gains

[sanderburwil]

$FLKS 1.70-$2.25+ on Merger announcement Salarius Pharma . Should hear news After hours possible late afternoon.

[sanderburwil]

Flex Pharma mergers news today can send this 100%+ . Salarius Pharmaceuticals and it’s CEO David Arthur highly recognized in the Bio world. FLKS $1.50+

[jaj-dan]

Clay is here again. With good news tomorrow we will break a buck for sure.

[ClayTrader]

* * $FLKS Video Chart 07-11-2019 * *

Link to Video - click here to watch the technical chart video

[jaj-dan]

80 gone. No stopping

[jaj-dan]

Looking great here today. Looks like we’ll be in dollar land by tomorrow. Agreed??

[jaj-dan]

I agree. IMO this could be the last chance to grab shares in the 50 cent range before merger confirmation.

[jpowellvlc]

GOOD, NAILED IT
manipulators

[jpowellvlc]

Stop loss hunters, i think

[turning stone]

I do not see any reason for the SP drop at the last few minutes of trading today. Points 2 and 3 have already been taken care of and point one if not accomplished makes the merger mute if not accomplished. Am I missing something somewhere?????

[jaj-dan]

I do not think that has been disclosed yet. The board members need to approve the merger first which should happen on July 12th meeting (pending share holder proxies). IMO this should be a good runner from now, at least till July 12.

[dhoff19]

Any word on what the reverse split would be?

[CrazyC]

8-K out... Not enough votes just yet and next meeting set for July 12, 2019...

https://www.sec.gov/Archives/edgar/data/1615219/000119312519173832/d746827d8k.htm

Item 5.07
Submission of Matters to a Vote of Security Holders.

On June 14, 2019, Flex Pharma, Inc. (“Flex Pharma” or “FLKS”) held its special meeting of stockholders. The purpose of the special meeting is described in Flex Pharma’s definitive proxy statement/prospectus/information statement dated April 29, 2019 (the “Proxy Statement”) relating to the pending merger with Salarius Pharmaceuticals, LLC (“Salarius”), which Flex Pharma first mailed to its stockholders on or about May 3, 2019.

At the special meeting, Flex Pharma determined that a quorum of stockholders was not present in person or by duly authorized proxy to transact business at the meeting and Flex Pharma adjourned the meeting. Flex Pharma announced that the adjourned meeting will be reconvened at the offices of Cooley LLP, 500 Boylston Street, 14th Floor, Boston, MA 02116, at 10:00 A.M. local time, on July 12, 2019.

Item 7.01
Regulation FD Disclosure.

Approximately 85% of shares voted by Flex Pharma’s stockholders to date support the merger. Flex believes this strong support is due to:

• recommendations by Institutional Shareholder Services (ISS) and Glass-Lewis (two leading U.S. institutional voting advisory services) to vote “FOR” each of the proposals in the Proxy Statement;

• ISS’s statement that “[t]he proposed transaction with Salarius appears to offer FLKS shareholders a better potential outcome than FLKS’ standalone business”;

• a unanimous recommendation by Flex Pharma’s board of directors to vote “FOR” each of the proposals; and

• the merger offering great future potential for Flex Pharma’s stockholders based on Salarius’ clinical pipeline, targeting a rare, orphan cancer with no targeted treatments and cancers with high unmet need using an epigenetic approach.

Flex Pharma urges stockholders to support the merger by voting as soon as possible FOR all the proposals in the Proxy Statement. Failure to vote, or a vote against any proposal, puts the merger at risk.

If Flex Pharma does not complete the merger, Flex Pharma likely will dissolve, liquidate or wind-up, and stockholders will likely lose most of the value of their investment.

Stockholders can vote by telephone, via the Internet or using the proxy card they received with their proxy materials. For any questions, or assistance in voting shares, or to receive additional copies of the proxy materials, stockholders should call proxy solicitor Innisfree M&A Inc., toll-free at 1 [phone].

[jaj-dan]

Hoping for another 2pm run like we had yesterday.

[jaj-dan]

I called the number where you vote your shares for the meeting today (i already voted last week) to see if I could get any updates. They could not disclose if they received enough votes for the board to approve the merger or if the meeting was taking place. The women on the phone said that info should be available by Monday or Tuesday.

[ClayTrader]

* * $FLKS Video Chart 06-13-2019 * *

Link to Video - click here to watch the technical chart video

[jpowellvlc]

agreed

[jpowellvlc]

0,9 NEXT

[jaj-dan]

Next stop .80

[jaj-dan]

.62 resistance broken!!!

[jaj-dan]

Hello? Is anyone home?

[jaj-dan]

Finally!!!!!!!!!!

[jaj-dan]

What is the deal with this merger? It's a bit confusing to me as to what it means for the pps being that us shareholders will only really have a 20% stake if the merger goes through?

[metalstocks]

Somebody front loading this before some possible news?

[ClayTrader]

* * $FLKS Video Chart 04-15-2019 * *

Link to Video - click here to watch the technical chart video

[lilzsuperboy]

heading up to $1 nicely

[lilzsuperboy]

[TrendTrade2016]

beasting oh my!!

[AugustaFriends]

this a 8x34 weekly breakout TA

[TrendTrade2016]

FLKS monster!!

[RT2GAIN]

RM play. Low float play.

[RT2GAIN]

Flex Pharma To Merge With Salarius To Accelerate Development Of Cancer Treatments -- MarketWatch https://research.tdameritrade.com/grid/public/markets/news/story.asp?docKey=1-DN20190104002686&cid=1-DN20190104002686-MIP